Advertisement
MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

MKGAFPNK
HealthcareDrug Manufacturers - Specialty & Generic
$163.23
$3.52(2.21%)
U.S. Market is Open · 11:57
Advertisement

MERCK Kommanditgesellschaft auf Aktien (MKGAF)

Meyka AI Score

Z

Key Financials

Market Cap67.9B
P/E Ratio23.19
EPS (TTM)$6.76
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$123.14
3 Months$136.54
1 Year Target$129.97

MKGAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKGAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $129.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.19 and a market capitalization of 67.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.23%
5-Day Change
-4.11%
1-Month Change
16.35%
3-Month Change
19.52%
6-Month Change
12.98%
Year-to-Date (YTD) Change
5.79%
1-Year Change
14.25%
3-Year Change
-13.22%
5-Year Change
-14.42%
All-Time (Max) Change
-75.53%

Contact Information

49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateAug 3, 2012
CountryDE
Actively Trading

Frequently Asked Questions